|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9,900.00% | -.--% | -.--% | -.--% | - | -.--% | -100.00% | -100.00% | - | 136 | |
| -3.74% | -6.32% | -7.99% | +11.77% | +4.16% | +42.70% | +63.37% | +190.17% | +5,979.80% | 55.2B | |
| -0.81% | -0.33% | -0.55% | +12.86% | +38.44% | +27.15% | +81.12% | -19.55% | - | 55.6B | |
| -0.34% | +0.81% | -0.26% | -10.29% | -2.51% | -15.67% | -14.75% | -71.73% | - | 23.51B | |
| -2.34% | -6.02% | -5.32% | -25.96% | -42.00% | -4.03% | +356.97% | +310.35% | +768.72% | 22.35B | |
| -4.01% | -2.68% | +7.14% | +11.37% | +20.23% | +12.50% | -12.70% | -69.66% | - | 20.6B | |
| -1.23% | -3.15% | +2.73% | +9.11% | -9.03% | +26.00% | -33.84% | -34.96% | +51.40% | 17.45B | |
| -3.34% | -6.96% | +10.42% | +4.61% | +22.64% | +22.02% | +515.48% | - | - | 15.16B | |
| +0.15% | -0.31% | +1.97% | +24.79% | +26.58% | +50.54% | +181.48% | +229.26% | +498.49% | 13.91B | |
| -5.09% | -13.14% | -10.47% | +75.74% | +141.92% | +151.85% | +272.20% | +1,322.52% | +585.75% | 13.74B | |
| -9.77% | -11.31% | -10.26% | -6.86% | -17.25% | +66.24% | +134.72% | +451.86% | +6,893.98% | 12.61B | |
| +0.50% | +0.14% | +6.61% | +18.26% | +30.89% | +453.33% | +151.74% | +25.41% | +1,382.94% | 12.14B | |
| -2.56% | -5.76% | +1.69% | -31.57% | -17.52% | -40.10% | +117.00% | +82.75% | - | 11.23B | |
| +2.21% | -2.04% | -5.80% | +25.45% | +26.30% | +121.81% | +140.63% | +170.38% | +598.43% | 10.64B | |
| +3.12% | -11.75% | -9.27% | -38.40% | -24.41% | -50.41% | +529.52% | +80.35% | +98.79% | 10.21B | |
| +0.02% | 0.00% | +0.36% | +25.09% | +23.23% | +56.50% | +155.59% | +561.12% | - | 9.83B | |
| -0.08% | +0.18% | +123.94% | +116.09% | +80.02% | +186.69% | +341.05% | +366.07% | - | 8.84B | |
| +1.71% | -0.65% | +11.89% | +33.43% | +203.24% | +474.55% | +603.17% | -35.18% | -16.70% | 8.61B | |
| -4.05% | -7.46% | -0.38% | -20.68% | +10.28% | +13.43% | +67.51% | -21.70% | - | 8.37B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +47.55% | +79.55% | - | 8.19B | |
| Average | +493.57% | -2.06% | +5.82% | +11.74% | +27.12% | +79.75% | +179.89% | +185.11% | +1,684.16% | 16.91B | |
| Weighted average by Cap. | -1.88% | -1.16% | +1.93% | +10.17% | +20.86% | +60.07% | +151.74% | +162.41% | +2,680.63% |
- Stock Market
- Stocks
- SEELQ Stock
- Sector Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
